Polycomb group (PcG) proteins act as positive regulators of cell proliferation. Ring1B is a PcG gene essential for embryonic development, but its contribution to cell turnover in regenerating tissues in not known. Here, we have generated a conditional mouse mutant line to study the Ring1B role in adult hematopoiesis. Mutant mice developed a hypocellular bone marrow that paradoxically contained an enlarged, hyperproliferating compartment of immature cells, with an intact differentiation potential. These alterations were associated with differential upregulation of cyclin D2, which occurred in all mutant bone marrow cells, and of p16 Ink4a , observed only in the differentiated compartment. Concurrent inactivation of Ink4a rescued the defective proliferation of maturing cells but did not affect the hyperproliferative activity of progenitors and resulted in a shortening of the onset of lymphomas induced by Ink4a inactivation. These data show that Ring1B restricts the progenitors' proliferation and promotes the proliferation of their maturing progeny by selectively altering the expression pattern of cell cycle regulators along hematopoietic differentiation. The novel antiproliferative role of Ring1B's downregulation of a cell cycle activator may play an important role in the tight control of hematopoietic cell turnover.
Adult multicellular organisms have evolved cell turnover strategies adapted to the maintenance and repair of tissues. In many cases, such as the hematopoietic system, gut, skin, and brain, tissue homeostasis depends on the activity of multipotent stem cells from which derive all the cell lineages that make these tissues (17, 56) . Because of the relatively small number of stem cells, their progeny undergoes an expanding but limited number of cell divisions along the differentiation process before entering the mitotically inactive state of fully mature cells. Tissue homeostasis, then, depends on an adequate balance between stem cell renewal, regulated cell proliferation, and terminal differentiation of stem cell progeny (58, 74) .
The Polycomb group (PcG) of proteins are transcriptional repressors that prevent the inappropriate expression of genes that determine cell identity (4, 11) . PcG gene products assemble in multimeric complexes (Polycomb repressing complexes [PRC] ) whose transcriptional activity is associated to their role as chromatin modifiers (64) . PRC are compositionally diverse, but depending on which of two sets of core subunits they contain, they are designated type PRC1 or PRC2 (40) . Histone H2AK119 monoubiquitylation depends on the RING finger E3 ligases of PRC1 complexes (10, 73) , whereas histone H3K27 trimethylation is carried out by PRC2 complexes (12, 18, 34, 46) . Well known as developmental regulators (57) , PcG genes also play important roles in cell proliferation control (41, 52) . Murine models of loss of function of PcG genes encoding PRC1 subunits show reduced size and hypocellularity of hematopoietic organs (1, 15, 69, 70) and also, in some cases (Bmi1) of brain structures (71) , indicating that PcG complexes are positive regulators of cell proliferation. The upregulation of PcG products observed in a wide variety of tumors (54, 68) and their cooperation in oncogene-induced tumorigenesis (27) further support a role for PcG complexes as promoters of proliferation. Exceptionally, inactivation of the PRC2 subunit Eed resulted in enlarged hematopoietic compartments (36) . These alterations are due, at least in part, to PcG-mediated repression of the Ink4a/Cdkn2a locus, which encodes the tumor suppressors p16
Ink4a and p19 Arf . Loss of function of PRC1 proteins, and Bmi1 in particular, results in premature senescence of hematopoietic and neuronal stem cells (28, 37, 44, 48, 49, 51) . PcG complexes also promote expansion of maturing cells by preventing senescence and apoptosis, although the contribution of each of these mechanisms varies depending on the particular tissue and the PcG protein (9, 14, 38, 45) .
Ring1B and its paralog Ring1A are the RING finger E3 ligases that monoubiquitylate H2A (20, 73) . They associate directly with Bmi1, Mel18, M33, and Phc1, forming the core of PRC1 complex(es) (25, 39, 63) . The contribution of Ring1A and Ring1B to cell turnover of renewing tissues is not known. Constitutive inactivation of Ring1A results in fertile mice with no overt phenotypes (19) , whereas inactivation of Ring1B leads to embryonic lethality due to defective gastrulation (72) . Considering that Ring1B expression in the adult hematopoietic compartment is detected in all differentiation stages, from the hematopoietic stem cells (HSCs) and their immature descendants (29), we sought to address the role of Ring1B in adult hematopoiesis using a conditional mutant mouse line. We find that Ring1B inactivation results in a reduction of total bone marrow cells and, at the same time, an enlargement of the immature cell compartment. We also show that the alterations in the size of bone marrow cell populations are due to cell proliferation defects caused by upregulation of components of the cell cycle machinery that act as activators (cyclin D2) or inhibitors (p16 Ink4a ) of proliferation in a differentiation stage-dependent manner. Finally, we observed premature development of lymphomas in compound Ring1B;Ink4a mutant mice that suggests an important role for Ring1B in controlling the expansion of progenitor cells in adult hematopoiesis.
MATERIALS AND METHODS
Mice, genotyping, and conditional inactivation of Ring1B. Ring1B genomic sequences for the targeting vector were generated from a partial genomic clone isolated from a mouse 129SVJ Lambda FIX II phage library (Stratagene) probed with a Ring1B cDNA. The 5Ј arm of the targeting vector was a 4,680-kb EcoRIBstNI fragment corresponding to sequences located 4,464 bp 5Ј from the intron 2-exon 3 junction, and the 3Ј arm was a 5,286-bp BstNI-EcoRI fragment encompassing sequences up to 97 bp 3Ј of the exon 5-intron 5 boundary. They were subcloned into pPGKneo2loxDTA plasmid (67) , which contains a phosphoglycerol kinase promoter-neomycin resistance gene cassette flanked by two loxP sites and a phosphoglycerol kinase-diphteria toxin gene cassette (see Fig. S1A in the supplemental material). The 5Ј arm was modified by inserting an oligonucleotide containing a loxP sequence and a BglII site at the AvrII site 197 bp 5Ј from the intron 1-exon 2 junction using a PCR strategy. The targeting construct was linearized and electroporated into 2 ϫ 10 7 mouse R1 embryonic stem (ES) cells. Colonies surviving the G418 selection were transferred into duplicated 48-well plates, which were used to prepare frozen stocks of the ES cell colonies and to isolate genomic DNA, respectively. The targeted allele was identified by Southern blotting using probes external to the targeting vector (see Fig. S1A in the supplemental material). Two Ring1B flox/ϩ (hereafter, Ring1B f/ϩ ) ES clones were aggregated with morulae obtained from C57Bl10 mice, and the resulting chimeric males were mated to C57Bl10 mice, and heterozygous animals were identified by Southern blotting. For routine genotyping, genomic DNA was analyzed by using a three-primer PCR (see Fig. S1A in the supplemental material).
For in vivo conditional inactivation, Ring1B flox/flox (hereafter, Ring1B f/f ) mice were crossed with MxCre transgenic mice (33) . MxCre expression was induced by intraperitoneally injecting 250 g of polyinosine-polycytidine (pIpC; Pharmacia) on three alternate days in 6-to 12-week-old mice. "Ex vivo" conditional inactivation of Ring1B was carried out on cells obtained from mice generated by crossing Ring1B f/f mice with RERT ert mice, a mouse line in which an IRES-Cre-ERT2 (tamoxifen-inducible Cre) cassette was knocked in into the 3Ј untranslated region of the RNA polII (Polr2a) gene (43) , to obtain Ring1B f/f ; RERT ert/ert mice (here termed Ring1B f/f CreERT2). Translocation of Cre-ERT2 to cell nuclei and loxP recombination were achieved by adding to the cultures 4Ј-hydroxy tamoxifen ([4-HT] 0.4 M final concentration; Sigma) or vehicle (ϩ4-HT and Ϫ4-HT cultures, respectively).
Compound Ring1B fl/fl ; Ink4a Ϫ/Ϫ mice were obtained by crossing Ring1B f/f mice with the Ink4a Ϫ/Ϫ mouse line (65) . Genotyping of the Ink4a allele was done by Southern blotting as described previously (65) . All mouse procedures were institutionally approved and were in accordance with national and European regulations.
Cell counting and blood analysis. Bone marrow cells were flushed out of both femurs with phosphate-buffered saline (PBS) containing 2% fetal calf serum (PBS-2% FCS) under sterile conditions. Spleens and thymi were disrupted in a Dounce homogenizer (loose pestle) in PBS-2% FCS. Cells were counted in a hemocytometer.
Blood was obtained by heart puncture immediately after mice were sacrificed. Blood counts were mostly performed by manual counting on a hemocytometer or automatically using an Abacus (Diatron) hematological analyzer. Manual counting of white blood cells was carried out after erythrocytic lysis.
Immunophenotyping and cell separation. Single-cell suspensions were washed with PBS and resuspended in cold washing solution (PBS-2% FCS-0.1% sodium azide). The appropriate antibodies were then added, and cells were labeled for 20 min at 4°C. After a washing step, cells labeled with biotin-conjugated antibodies were further incubated with streptavidin conjugated to phycoerythrin (PE) or peridinin chlorophyll protein-Cy5.5. Samples were acquired in a FACScan fluorescence-activated cell sorter (FACS) instrument with CellQuest software or a FACSCanto with Diva software, all from Becton Dickinson. The antibodies that were used were as follows: c-Kit conjugated to fluorescein isothiocyanate (FITC), biotin, or allophycocyanin (for analysis); Sca-1, Gr-1, CD41, and B220 conjugated to FITC or biotin; Mac-1, CD3, and Ter119 conjugated to biotin; CD34 conjugated to FITC; Fc␥R and CD19 conjugated to PE. All antibodies were purchased from BD Biosciences.
For common myeloid progenitor (CMP) sorting, isolated colonies with immature phenotype were pooled, immunomagnetically depleted of Lin ϩ cells, and labeled with anti-c-Kit-allophycocyanin -, anti-CD34-FITC-, and anti-Fc␥R-PEconjugated antibodies and sorted on the c-Kit ϩ /CD34 ϩ /Fc␥R lo gate in a FACS Vantage sorter equipped with a Diva system (BD Biosciences), set to render the highest purity. Immunomagnetic cell isolation was done using a Lineage Cell Depletion kit and LD columns together with a QuadroMACS separation unit from Miltenyi Biotec. Hematopoietic cell subpopulations for Ring1B expression analysis were isolated by cell sorting as described previously (30) , using Mac1 
Gr1
lo for monocytic and Mac1 ϩ Gr1 high for granulocytic precursors, respectively, in a FACS Vantage sorter (BD Biosciences).
In vitro colony forming assays. Myeloid and pre-B-cell colony plating assays were performed in cytokine-supplemented methylcellulose-based medium M3434 and M3630 (StemCell Technologies), seeding total bone marrow in duplicate (2 ϫ 10 5 or 2 ϫ 10 4 cells/35-mm dish for pre-B-cell and myeloid assays, respectively). For assays of isolated progenitors, 500 Lin Ϫ cells were used per plate. Myeloid cultures were scored for colony formation and morphologically analyzed at day ϩ12 unless otherwise specified. Pre-B-cell and immature myeloid colonies were systematically scored at day ϩ8 and day ϩ7 after seeding, respectively. Serial replating, using equal numbers of cells, was performed 10 days after plating.
Cell proliferation, cell division, and apoptosis assays. Bone marrow or isolated Lin Ϫ cells were cultured in 24-well plates containing Iscove's modified Dulbecco's medium-10% FCS medium plus 20 or 50 ng/ml of recombinant murine interleukin-3 (IL-3) or recombinant human IL-6, respectively (Peprotech). Recombination in cultured cells was achieved by adding 4-HT (0.4 M; Sigma) or vehicle, where indicated. Lin Ϫ cells cultures also contained 100 ng/ml of recombinant human stem cell factor (Peprotech). Viable cells were counted by trypan blue exclusion in a hemocytometer.
Bromodeoxyuridine (BrdU) incorporation was assessed by adding the nucleotide precursor analog to the culture medium at a final concentration of 10 M. After 18 h labeled cells were determined with a flluorochrome-conjugated antiBrdU antibody (FITC BrdU flow kit; BD-Pharmingen) and analyzed by flow cytometry in a FACScan cytometer equipped with CellQuest software (BD Biosciences). For cell division assays, cells were labeled with 2 M carboxyfluorescein diacetate succinimidyl ester (CFDA-SE) and handled as indicated by the manufacturer (Invitrogen). Cell-associated fluorescence was analyzed by flow cytometry 18 h later. To determine the fluorescence associated to cells before division, two aliquots were removed: one was analyzed immediately, and the second was kept at 4°C to match the analysis conditions. An FITC-conjugated recombinant human annexin V kit (Bender Medsystems) was used to stain apoptotic cells prior to flow cytometry analysis.
Western blotting analysis. Cells were lysed in radioimmunoprecipitation assay buffer (10 mM Tris-HCl, pH 7.2, 150 mM NaCl, 1% TX-100, 0.1% sodium dodecyl sulfate, 1% deoxycholate, 5 mM EDTA, 20 mM NaF, 100 M orthovanadate, and protease inhibitors) for 30 min on ice. Cell lysates were cleared of debris by centrifugation at 15,000 ϫ g for 15 min, aliquoted, snap-frozen, and kept at Ϫ70°C until used. Thirty micrograms of total protein was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to BioTrace polyvinylidene difluoride membranes (Pall Corporation) for 1 h at 2 mA/cm 2 on a semidry transfer apparatus (Amersham). Ponceau staining was routinely performed on membranes, and digital photographs were taken in order to record a sample loading control. After being blocked in Tris-buffered saline containing 0.1% Tween 20 and 5% nonfat dry milk, filters were incubated VOL. 28 Arf (ab80; Abcam). After a washing step and incubation with horseradish peroxidase-conjugated secondary antibodies (Dako), signals were detected using an enhanced chemiluminescence system (Pierce).
Histopathology and immunohistochemistry. Normal and tumor tissue samples were fixed in 10% neutral-buffered formalin for 24 h. After dehydration and paraffin wax embedding, 3-m sections were prepared and stained with hematoxylin and eosin. For immunohistochemical analysis, sections were mounted on poly-L-lysine-coated slides, and anti-Pax5 antibodies were detected by the avidinbiotin-peroxidase complex method (Peroxidase Elite, Vectastain, and ABC kit; Vector Laboratories).
Quantitative reverse transcription-PCR expression analysis. RNA was isolated from sorted hematopoietic cell populations using an RNeasy kit (Qiagen). Random-primed cDNA was generated using a Superscript III First Strand reverse transcription kit (Invitrogen). Triplicate reactions of cDNA amplification were performed in Sybr Premix Ex Taq (Takara) and analyzed using a 7900HT Fast Real-Time PCR System (Applied Biosystems). Relative mRNA normalized to acidic ribosomal phosphoprotein mRNA levels was determined using the comparative cycle threshold (⌬⌬C T ) method. The following sets of primers were used: for Ring1B, TTGACATAGAATGGGACAGC (forward) and GTCAGC AGAAAGTCTTGTGG (reverse); for acidic ribosomal phosphoprotein, CGAC CTGGAAGTCCAACTAC (forward) and ATCTGCTGCATCTGCTTG (reverse).
ChIP. Lin Ϫ and Lin ϩ bone marrow cells were processed for chromatin immunoprecipitation (ChIP) assays using anti-trimethylated H3K27 (Upstate), anti-Ring1B (3), and anti-Bmi1 (21) antibodies. Immunoprecipitated DNA was amplified using the primer pair TTGCCCTGAATATAGCATGA and TCATG CTATATTCAGGGCAA or the pair CGATCCTTTAGCGCTGTTTC and CA CACTCTGCTCCTGACCTG that span 271 bp and 201 bp in the murine p16
Ink4a gene promoter area, respectively. Statistical analyses. Values are expressed as means Ϯ standard deviation (SD). Data sets were compared using a two-tailed Student's t test, and differences were considered significant for P values of Ͻ0.05.
RESULTS
Loss of Ring1B leads to concurrent bone marrow hypocellularity and enlarged immature cell compartments. Ring1B mRNA expression was found to be ubiquitous in hematopoietic cells, from the most primitive HSC and its derived progenitors (CMP and common lymphoid progenitor) through more committed but still immature bivalent progenitors (granulo-monocytic progenitors [GMPs] and megakaryoerythrocytic progenitors [MEP] ) and the most mature myeloid and lymphoid cells (Fig. 1A) . To study the function of Ring1B during adult hematopoiesis, we crossed a pIpC-inducible MxCre mouse line that expresses the Cre recombinase in the hematopoietic compartment (33) with a conditional Ring1B f/f mouse line (Fig. 1B) to produce Ring1B f/f ; MxCre mice and their MxCre-negative littermate controls. Six-to 12-week-old mice were treated with pIpC and sacrificed 4 weeks later. The treatment resulted in efficient deletion of alleles flanked by loxP sites (see Fig. S1A in the supplemental material) and loss of Ring1B protein in the bone marrow (Fig. 1B) .
Examination of circulating blood cells and secondary hematopoietic organs (spleen and thymus) of MxCre-positive and MxCre-negative mice showed only mild, but consistent, reduction of erythrocytes and splenocytes in most mutant animals and a few thrombocytotic individuals (see Fig. S2A and B in the supplemental material). Immunophenotypic analysis of bone marrow cells showed no remarkable differences in lineage composition between normal and mutant mice, except for a slight decrease of mutant lymphoid B cells (see Fig. S2C in the supplemental material). A relevant difference, however, was seen in total bone marrow cell numbers, which were reduced upon Ring1B ablation by nearly one-third (P ϭ 0.001) (Fig. 1C) . In contrast, the progenitor compartment (minority cells lacking lineage differentiation markers, i.e., Lin Ϫ cells) was enlarged in mutant bone marrow (Fig. 1D) . The HSCenriched subpopulation (Lin Ϫ cells that simultaneously express c-Kit and Sca-1 markers) was also larger than that of Ring1B-expressing cells (Fig. 1E) . Thus, Ring1B ablation resulted in concurrent hypocellularity of the mature bone marrow and an increased number of progenitor cells, with no apparent alterations in lineage specification.
Cell-autonomous increase of Ring1B-deficient myeloid clonogenic cells. Clonogenic assays were employed to determine the abundance of cells (CFU) able to expand and give rise to differentiated progeny in vitro. These include primitive, multilineage progenitors and immediate unilineage precursors that give rise to characteristic, morphologically distinguishable colonies. For lymphoid cells, clonogenic assays in the presence of IL-7 revealed a severe reduction in the number and size of Ring1B-deficient pre-B-cell colonies ( Fig. 2A) . On the other hand, ablation of Ring1B resulted in an almost twofold increase of myeloid CFU (Fig. 2B) . Whereas all types of supported CFU were represented, their relative proportions were altered, particularly the mixed granulo-mono-erythromegakaryocitic (GEMM) colonies (sixfold increase; P Ͻ 0.0001) (Fig. 2B ) originated from the most immature progenitors. The GEMM colonies derived from blast-like cell clusters, which in mutant bone marrow cultures appeared invariably denser (Fig. 2C , top) and also contained a higher proportion of the primitive CMP (fivefold increase; P ϭ 0.05) (Fig. 2C, bottom) . We conclude that Ring1B clearly affected both the size and clonogenic activity of the progenitors' compartment.
Since extrinsic signals affect hematopoiesis, we aimed to determine the cell-autonomous contribution to the above alterations. To do this, we devised an ex vivo Ring1B inactivation system that used bone marrow cells from Ring1B f/f ; Cre-ERT2 mice. These were obtained by crossing the conditional Ring1B f/f mouse line with a RERT ert mouse deleter line (Cre-ERT2::Polr2a [43] ) (see Fig. S3A in the supplemental material). The mouse deleter line ubiquitously expresses a tamoxifen (4-HT)-inducible fusion protein between the Cre recombinase and a mutated ligand binding domain of the human estrogen receptor. Bone marrow cells from these mice were cultured in parallel in the absence (Cre Ϫ ) and in the presence (Cre ϩ ) of 4-HT to generate control and Ring1B-deleted cells, respectively. Efficient Ring1B ablation was achieved 2 days after 4-HT treatment (see Fig. S3B in the supplemental material). As seen above for in vivo Ring1B-inactivated bone marrow cells ( Fig. 2A and B) , 4-HT treatment resulted in a reduction of pre-B-cell colonies, an increase in total Lin Ϫ cells, and a larger number of myeloid CFU (see Fig.  S3C to E in the supplemental material). Consistent with this, mutant progenitors (ϩ4-HT; Cre ϩ ) yielded more secondary and tertiary colonies in a replicating assay than control progenitors (Ϫ4-HT; Cre Ϫ ), indicating a higher self-renewal rate of Ring1B-deficient cells (Fig. 2D) . These results indicate that alteration of immature cell populations and of their clonogenic activities are mostly due to a cell-autonomous defect resulting from the ablation of Ring1B.
Ring1B inactivation enhances the proliferative rate of myeloid progenitors. We used ex vivo inactivation of Ring1B to investigate whether differences in cell proliferation rate, apoptosis, or cell differentiation could account for the accumulation of Ring1B-deficient primitive hematopoietic cells. Pulse labeling of Lin Ϫ cells with BrdU demonstrated that more cells incorporated BrdU in 4-HT-treated (Cre ϩ ) than in nontreated (Cre Ϫ ) cultures (Fig. 3A) . We also used CFDA-SE fluorescence decay as an additional test of the cell division rate. This assay is based on the dilution of the fluorescent dye resulting from its equal distribution among daughter cells upon cell division. As shown in Fig. 3B , nearly all Ring1B-deficient Lin Ϫ cells had completed one cell cycle at the same point when 30% of the Ring1B-expressing Lin Ϫ cells still remained undivided. Under these culture conditions, annexin V labeling (an indicator of apoptosis) showed no differences between treated and nontreated cultures (Fig. 3C) . These results indicate that the enlargement of the mutant Lin Ϫ compartment is due to an increase in the cell proliferation rate provoked by the loss of Ring1B.
Although the representation of the various lineages in bone marrow and circulating cells in Ring1B mutant mice suggested that no major alterations in differentiation were occurring, we further tested this by immunophenotyping cells generated in methylcellulose cultures of Lin Ϫ cells. As seen in Fig. 3D , levels of Gr-1, Mac-1, and CD-41 lineage markers (specific for granulocytes, monocytes, and megakaryocytes, respectively) showed no differences between cultures from Ring1B-deleted and nondeleted Lin Ϫ cells. Moreover, FACS-sorted mutant CMPs retained the ability to give rise in vitro to more mature progeny, MEPs and GMPs (Fig. 3E) . Together, these data The results are shown as the mean Ϯ SD (n ϭ 6) of the total number of secondary and tertiary colonies generated from identical numbers of pooled primary control (Ϫ4-HT) and mutant (ϩ4-HT) myeloid colonies.
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Ring1B negatively regulates cyclin D2 and p16
Ink4a . After establishing the role of Ring1B in proliferation of hematopoietic cells, we began to study the underlying mechanism(s) by analyzing protein expression levels of known cell cycle regulators. The rate of cell proliferation in mammalian cells is determined mainly in the G 1 phase of the cell cycle by the specific activation of cyclin-dependent kinases, which are in turn negatively regulated by two families of cyclin-dependent kinase inhibitors (CKIs) (66) . First, we compared total bone marrow cell extracts from control MxCre-negative and in vivo deleted Ring1B (MxCre positive) mice. Western blot analysis showed increased levels of cyclin D2 (Fig. 4A) and also of the cell cycle progression indicator cyclin A (see Fig. S4A in the supplemental material) in extracts from Ring1B-deficient cells. Also, levels of the CKI p27 appeared slightly higher in mutant cells (see Fig. S4 in the supplemental material) . However, the most prominent difference was observed for the levels of p16 Ink4a , another CKI which, while undetectable in extracts from nondeleted cells, gave a strong signal in Ring1B-deficient cell extracts (Fig. 4A) . No signals were detected for cdc6, a component of the replication licensing machinery, the CKI p57, or p19
Arf in any of the extracts (see Fig. S4A in the supplemental material).
Since the most immature cells (i.e., HSCs and progenitors) represent only a minor contribution to total bone marrow cells, we performed Western blot analysis on mutant and control Lin Ϫ cells (Fig. 3B) . In contrast to whole bone marrow, the expression pattern of cell cycle regulators in mutant Lin Ϫ cells showed an upregulation of proliferation activators cyclin D2 ( Fig. 4B, left) , cyclin A, and cdc6 (see Fig. S4A in the supplemental material) with a concomitant absence of proliferation inhibitors p16
Ink4a (Fig. 4B, left) , p27, and p57 (see Fig. S4A in the supplemental material). However, the analysis of colonies harvested from Lin Ϫ cell methylcellulose cultures at day 8 showed a sustained upregulation of cyclin D2 together with a dramatic increase of p16
Ink4a levels in maturing Ring1B-deficient cells only (Fig. 4B, middle panel) , thus resembling the expression pattern seen in unfractionated bone marrow cells. A similar upregulation of p16
Ink4a levels was observed in extracts from cultured mutant pre-B cells (Fig. 4B, right) . Only cyclin D3, which is needed for the expansion of pre-B cells Ink4a gene locus shows exons and coding (filled) sequences and the amplicon used for ChIP assays. Lin Ϫ and Lin ϩ cell populations were immunomagnetically isolated from bone marrow and chromatin analyzed using the indicated antibodies (bottom). Ex, exon; H3K27me3, trimethylated H3K27; IgG, immunoglobulin G; d, day.
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at RIKAGAKU-KENKYUSHO on January 21, 2008 mcb.asm.org (13) , was detected in these cells, and its expression was hardly affected by the lack of Ring1B in either pre-B cells or myeloid cells (see Fig. S4C in the supplemental material), suggesting that the effect on cyclin D2 is specific. Modest increases in p27 and p57 levels were also observed in maturing mutant cells (see Fig. S4B in the supplemental material) . These data show that Ring1B inactivation alters the expression pattern of cell cycle regulators in differentiating cells and suggest that the resulting populations of mature and immature cells are endowed with reduced and enhanced proliferation rates, respectively. We investigated these cell populations by using liquid cultures of ex vivo Ring1B-ablated Lin Ϫ cells under conditions that recapitulate the differentiation events occurring in normal myelopoiesis. Initially after treatment, the relative accumulation of cells was faster in mutant (ϩ4-HT; Cre ϩ ) than in control (Ϫ4-HT; Cre Ϫ ) cultures (Fig. 4C) . However, by day 6 after treatment, this ratio was inverted, and Ring1B-expressing cultures contained more cells than those of Ring1B-deficient cells. Analysis of CFDA-SE fluorescence decay confirmed the inversion of cell division rates between days 4 and 6 after 4-HT (Fig. 4D) treatment. The lower accumulation of mutant cells did not result from increased cell death, as determined by annexin V staining (Fig. 4E) . Instead, the late upregulation of p16 Ink4a , detected only by day 6 after treatment ( Fig. 4F) , correlated with the switch in proliferation rate. This contrasted with the prompt upregulation of the proliferation promoter cyclin D2 in mutant cultures (Fig. 4F) , which, in the absence of the inhibitor p16
Ink4a , would explain the enhanced proliferation observed before day ϩ6. A possible explanation for the differential regulation of p16 Ink4a in immature versus mature cells may be related to the decreasing levels of Bmi1 during hematopoietic differentiation (26) , which would ensure p16
Ink4a silencing in progenitors, even in the absence of Ring1B. We tested this by analyzing promoter occupancy at the Ink4a locus in ChIP assays and found that whereas Ring1B was detected in both immature Lin Ϫ and maturing Lin ϩ cells, Bmi1 was seen associated predominantly in the immature compartment (Fig. 4G) .
Collectively, these results show that through the balanced expression of positive and negative cell cycle regulators, Ring1B controls the expansion of differentiating hematopoietic cells both by restricting proliferation of progenitors and by contributing to their expansion during maturation.
Ink4a deficiency rescues only the expansion defects of Ring1B-deficient hematopoietic cells. Given the correlation seen between p16
Ink4a upregulation and proliferation inhibition in maturing ex vivo Ring1B-deleted cells, the overall decrease of bone marrow cells associated with Ring1B inactivation could be explained by similar mechanisms. To test this hypothesis, we crossed Ring1B f/f ; MxCre and Ring1B f/f mice with a mouse line carrying an Ink4a null mutation which does not express either p16
Ink4a or p19 Arf (65) . Bone marrow analysis after pIpC-induced Ring1B ablation showed that inactivation of the Ink4a locus abolished the differences in cellularities of bone marrow and spleen observed in single Ring1B-deficient cells (Fig. 5A) . Furthermore, the severe reduction of pre-B-cell colonies associated with Ring1B inactivation was not observed in cultures of bone marrow cells that were also deficient in Ink4a, which showed even a further increase in the number and size of pre-B-cell CFU (Fig. 5B) . In contrast, the increased number of Ring1B-deficient myeloid CFU was not affected by the lack of Ink4a (Fig. 5C) , although the enlarged size of double mutant colonies indicated that Ink4a products could act by restricting the proliferative potential of maturing Ring1B-deficient cells. Since p19
Arf is not affected by Ring1B inactivation, the results confirm that the proliferative deficits of Ring1B-deficient hematopoietic cells are due to the upregulation of p16
Ink4a in maturing cells. Ring1B deficiency results in an accelerated onset of hematopoietic neoplasias in the absence of Ink4a. Mice with an inactive Ink4a locus spontaneously develop and succumb to a variety of tumors, mostly fibrosarcomas and lymphomas (62, 65) . Remarkably, compound Ring1B; Ink4a mutant mice presented a quicker onset of fatal disease that lead to an acceleration of the death rate, on average 11 weeks after Ring1B ablation, as indicated in the survival plot shown in Fig. 6A . Four out of the six compound mutant mice which could be subjected to necropsy had developed splenomegalia and hepatomegalia (Fig. 6B, left) , resulting from infiltration by cells which expressed the lymphoid marker Pax5 (Fig. 6E, right) . The results show cooperation between the loss of function of a tumor suppressor (Ink4a) and the inactivation of Ring1B, which is in agreement with a role for Ring1B as a negative regulator of cell proliferation.
DISCUSSION
Elucidating the mechanisms underlying tissue self-renewal is important to understanding neoplastic processes. In this study, we provide genetic evidence supporting a distinctive role for the Polycomb protein Ring1B in the regulation of adult hematopoiesis. We find that Ring1B controls hematopoietic cell proliferation by acting as not only a positive regulator, as other PRC1 members, but also a negative regulator, depending on the maturational stage of cell differentiation. Thus, while restricting proliferation of early myeloid progenitors, Ring1B is needed for the expansion of maturing, cell lineage-committed precursors of both myeloid and lymphoid B-cell lineages. We demonstrate that these effects are mediated, at least in part, via downregulation of opposing cell cycle regulators, the G 1 cyclin D2 and its inhibitor p16
Ink4a . Dual roles of Ring1B in positive and negative regulation of cell proliferation through downregulation of cell cycle inhibitors and activators. The hematopoietic compartment is among the tissues most affected by mutations in PcG genes, resulting in smaller thymi and spleens and a hypocellular bone marrow (36, 55) . Inactivation of Ring1B results in a hematopoietic phenotype milder than that of other PRC1 mutant mice but equally consistent with a positive role in cell proliferation. However, the enlargement of the size of the mutant progenitor compartment indicates that Ring1B also acts as an antiproliferative regulator. The accumulation of Ring1B-deficient immature cells seems to be due mostly to their hyperproliferative phenotype rather than to reduced apoptosis or defective differentiation. Thus, the antiproliferative activity of Ring1B contrasts with the most prominent role of other PRC1 subunits as proliferation promoters, e.g., Bmi1. It also resembles that of the PRC2 component Eed, whose inactivation antagonizes the effects of a Bmi1 mutation (35) . Moreover, the use of an ex vivo inactivation model shows that these proliferative alterations are, at least in part, the result of Ring1B cell-autonomous regulated events.
In agreement with a dual role for Ring1B in negative and positive regulation of cell proliferation, we find that Ring1B targets both cell cycle activators and inhibitors. Usually, the activity of PcG proteins as promoters of cell proliferation is associated to their role as repressors of the Ink4a locus (23) . We find that the inactivation of Ring1B also causes upregulation of p16
Ink4a but not of p19 Arf , similarly to the previous observation of Ink4a mRNA selective derepression in constitutively Ring1B-deficient mouse embryos (72) . In addition, our analysis demonstrates that Ring1B regulates negatively the G 1 cyclin D2 and the replication factor cdc6, two characteristic promoters of cell proliferation.
Repression by PcG complexes usually refers to the mechanisms dealing with maintenance of transcriptionally silent loci. An example is the Ink4a/Arf locus, which is normally inactive in proliferating cells. Association of PcG components, including Ring1B, to genomic regions of Ink4a/Arf and its correlation with the repressed state are considered indications of direct transcriptional control (6, 21, 31) . On the other hand, negative regulation of transcriptionally active loci, such as cyclin D2 in proliferating cells, appears as a novel scenario for Polycomb repression. However, studies in Drosophila melanogaster show that the Cyclin A gene, the product of which is needed for cell cycle progression, is repressed by PRC1 subunits, Polycomb and Polyhomeotic (42) . Furthermore, Polycomb was found associated to the Cyclin A locus, just as Ring1B and Bmi1 appear bound to regions of the Cyclin D2 gene in ES cells and fibroblasts (5, 7). It is likely, then, that the presence of Polycomb complexes in the proximity of regulatory regions of active loci (6, 8, 50) may serve a regulatory role for fine-tuning of the transcriptional response. Regardless of the underlying mechanism(s), the finding that Ring1B negatively regulates cyclin D2 reinforces the notion that the role of PcG complexes in cell proliferation includes the regulation of components of the machinery involved in cell cycle progression.
Selective regulation of hematopoietic cell proliferation by Ring1B and other PcG products. Normal hematopoiesis displays an orchestrated use of the cell cycle machinery components in order to ensure the self-renewal and expansion activities associated with the various stages of cell differentiation of hematopoietic lineages (53) . These include proliferative responses as diverse as the high self-renewal capacity and low proliferative rate of HSCs, the various proliferation rates of their progeny along their maturation, or retrieval from active proliferation of fully differentiated cells (58) .
In our studies, Ring1B inactivation resulted in upregulation of cyclin D2 in most hematopoietic cells analyzed, except for B-cell precursors, whereas that of p16
Ink4a was detected only in maturing B and myeloid cells but not in progenitors, thus providing an explanation for their altered proliferation rates. Mutant myeloid progenitor hyperproliferation would result from increased cyclin D2, in the absence of p16 Ink4a , as it occurs in Cyclin D2-transduced bone marrow cells (61) . In turn, progressive accumulation of p16
Ink4a along differentiation would abrogate the proliferative potential of the maturing progeny, despite their high content of cyclin D2, thereby resulting in a hypoplastic bone marrow. In this simple hypothesis, inhibition, but not promotion, of proliferation caused by Ring1B inactivation would be alleviated by loss of p16
Ink4a . Indeed, myeloid and B-cell precursors of mice bearing a coincident loss of Ring1B and Ink4a proliferate efficiently, and the reduced cellularity of Ring1B-deficient bone marrow is restored in the compound mutant. Instead, the hyperproliferative phenotype elicited by Ring1B inactivation in myeloid progenitors was not reversed by the absence of Ink4a. Altogether, our data support a broad regulatory role for Ring1B in the differentiation/expansion of adult hematopoietic cells by integrating signals during amplification of immature progenitors and during the expansion of their maturing progeny (Fig. 7) .
The contrasting differences between hematopoietic alterations associated with Ring1B ablation and those seen in mice lacking some of their interacting partners in PRC1 complex(es), i.e., Bmi1, Mel18, M33, and Mbt1 (1, 14, 71) , are likely a reflection of differential targeting in distinct cell types by complexes that vary in composition or activity. For instance, maintenance of repression of Ink4a/Arf in HSCs and early progenitors occurs in the absence of Ring1B but not in the absence of Bmi1 (48); another example is the p57 derepression in Mbt1-null myeloid progenitors (2) . Given the increasing biochemical diversity of Ring1B-containing complexes (22, 47, 59) , it appears that a definition of the expression pattern of their subunits throughout the differentiation stages of the various lineages will be needed for a comprehensive understanding of Polycomb complex function in hematopoiesis.
Ring1B-Ink4a interaction: implications for tumorigenesis. The role of Ring1B as a proliferation promoter through repression of inhibitors of cell proliferation is consistent with the rescue of Ring1B-deficient bone marrow hypocellularity by Ink4a/Arf inactivation. This observation is reminiscent of the substantial restoration of the self-renewing capacity of HSCs (48) and of thymocytes and splenocytes of Bmi1 Ϫ/Ϫ Ink4a/ Arf Ϫ/Ϫ mice (9). Bmi1-mediated repression of Ink4a appears as a causal agent of primed cell proliferation in tumors, and protein expression analysis shows upregulation of Bmi1 in a variety of tumor cells. Similarly, Ring1B protein expression is increased in a variety of tumors (60) , and its expression correlates with poor prognosis in a subset of malignant human cancers (24) . However, the antiproliferative activity of Ring1B may also play a role in the development of neoplastic processes, as suggested by the decreased latency of tumor development in mice whose bone marrow is doubly Ring1B and Ink4a/Arf deficient compared to those lacking only Ink4a/Arf. Since Ring1B inactivation does not lead to p19
Arf upregulation, the contribution of Ring1B in the absence of p16
Ink4a to neoplastic events may lie in the presence of a population of progenitors with enhanced self-renewal properties susceptible of transformation (16, 32) , thus cooperating with other genetic/ epigenetic lesions appearing during the onset and development of tumors.
In conclusion, we have identified an antiproliferative role for Ring1B in the expansion of progenitor cells, mediated by the suppression of a positive regulator of the cell cycle machinery, which may be important in the tight control of proliferation occurring during adult hematopoiesis. It will be of interest to investigate whether this role in cell turnover takes place also in other self-renewing tissues. FIG. 7 . Proposed model for Ring1B proliferation control during hematopoiesis. During normal hematopoiesis, Ring1B regulates progenitor and precursor cell expansion by controlling the balance between positive and negative proliferating signals. In Ring1B-deficient hematopoietic cells, proliferation activators cyclin D2 and cdc6 are upregulated in myeloid progenitors whereas the p16 Ink4a proliferation inhibitor is upregulated only in more mature myeloid and lymphoid precursor cells. As a result, the early myeloid progenitor population is expanded whereas B-cell and myeloid maturing cell populations are reduced. 
